Sequential intermediate high-dose chemotherapy in the primary treatment of poor risk testicular cancer

Bone Marrow Transplantation

Volumn 18, Issue SUPPL. 1, 1996, Pages

  Schmoll, H J ^a   Bokemeyer, C ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CISPLATIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE;

BONE MARROW TOXICITY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; MULTICENTER STUDY; NEPHROTOXICITY; NEUROTOXICITY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; STEM CELL TRANSPLANTATION; TESTIS CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IFOSFAMIDE; MALE; REMISSION INDUCTION; TESTICULAR NEOPLASMS;

EID: 0029913490     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Mead GM, International consensus prognostic classification for metastatic germ cell tumours treated with platinum based chemotherapy; final report of the International Germ Cell Cancer Collaborative Group (IGCCCG). Proc ASCO 14: Abstract-No 615, (1995)
2. Fossa SD, AN MRC/EORTC randomized trial in poor prognosis metastatic teratoma, comparing treatment with/without filrastim (G-CSF). Proc ASCO 14: Abstract-No.656 (1995)
3. Siegert, W., J. Beyer, I. Strohscheer, H. Baurmann, H. Oettle, J. Zingsem, R. Zimmermann, C. Bokemeyer, H.-J. Schmoll, D. Huhn. High-dose treatment with carboplatin, etoposide and ifosfamide followed by autologous stem cell transplantation in refractory germ cell cancer - A phase I/II study. J Clin Oncol 12(6):1223-1231 (1994)
4. Beyer, J., A. Kramar, R. Mandanas, W. Linkesch, A. Greinix, J.P. Droz, J.L. Pico, A. Diehl, C. Bokemeyer, H.-J. Schmoll, C.R. Nichols, L.H. Einhorn, W. Siegert High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognosis variables. J Clin Oncol (1996) (in press)
5. Nichols, CR., William, SD, Loehrer, PJ. et al. Randomized study of Cisplatin dose intensity in poor risk germ cell tumors: A South Eastern Cancer Study Group and South West Oncology Group Protocol. J Clin Oncol 9 (7), 1163-1172 (1991)